Stepping Into the Era of Combination Cancer Therapies, Part 1: Combining Immunotherapies

Game-changing modern cancer therapies—immunotherapies and targeted therapies, among others—have been providing promising treatment outcomes in the recent years. The outcomes with immunotherapies, in particular, are so compelling that cancer clinicians …

Read More

New Immunotherapy Advances Presented at the AACR Annual Meeting 2015

Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial results that led to U.S. Food and Drug Administration (FDA) approvals …

Read More